Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > CEO on Recent News

View:

Post by SkywalkerofLuke on Jun 01, 2023 5:53pm

CEO on Recent News

A recent study found that Chronic Kidney Disease affects “as many as 40% of the elderly population in Canada and other developed countries” = a large addressable market for AGN.c AGNPF who were granted a patent in Japan for treating CKD with drug NP-251 or Repirinast.

Repirinast highlights

- Has data showing it reduced fibrosis by 51%

- Showed an additive benefit to medicine blood pressure drug telmisartan in a mouse model

If AGN can continue testing Repirinast and prove it’s effective against CKD the opportunity for them is huge. Especially considering they are sitting with a $2.27M MC.

CEO discusses more about the method of use patent in this interview.

https://www.youtube.com/watch?v=H04k_Ek6gPI

165